Sfoglia per Autore
Design and application of oncolytic viruses for cancer immunotherapy
2020 Ylosmaki, E.; Cerullo, V.
Exploiting preexisting immunity to enhance oncolytic cancer immunotherapy
2020 Tahtinen, S.; Feola, S.; Capasso, C.; Laustio, N.; Groeneveldt, C.; Ylosmaki, E. O.; Ylosmaki, L.; Martins, B.; Fusciello, M.; Medeot, M.; Tagliamonte, M.; Chiaro, J.; Hamdan, F.; Peltonen, K.; Ranki, T.; Buonaguro, L.; Cerullo, V.
Application of array-comparative genomic hybridization analysis in immune-virotherapy approach
2020 Vitale, A.; Capasso, C.; Leggiero, E.; Garofalo, M.; Kuryk, L.; Hirvinen, M.; D'Alessio, F.; Perrotta, C.; Verdesca, F.; Ranieri, A.; Salvatore, F.; Pastore, L.; Buono, P.; Cerullo, V.; Lombardo, B.
Uncovering the tumor antigen landscape: What to know about the discovery process
2020 Feola, S.; Chiaro, J.; Martins, B.; Cerullo, V.
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma
2020 Polini, B.; Carpi, S.; Doccini, S.; Citi, V.; Martelli, A.; Feola, S.; Santorelli, F. M.; Cerullo, V.; Romanini, A.; Nieri, P.
Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction
2020 Torrieri, G.; Fontana, F.; Figueiredo, P.; Liu, Z.; Ferreira, M. P. A.; Talman, V.; Martins, J. P.; Fusciello, M.; Moslova, K.; Teesalu, T.; Cerullo, V.; Hirvonen, J.; Ruskoaho, H.; Balasubramanian, V.; Santos, H. A.
Artificially cloaked viral nanovaccine for cancer immunotherapy
2019 Fusciello, M.; Fontana, F.; Tahtinen, S.; Capasso, C.; Feola, S.; Martins, B.; Chiaro, J.; Peltonen, K.; Ylosmaki, L.; Ylosmaki, E.; Hamdan, F.; Kari, O. K.; Ndika, J.; Alenius, H.; Urtti, A.; Hirvonen, J. T.; Santos, H. A.; Cerullo, V.
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks
2019 Kuryk, Lukasz; Møller, Anne-Sophie W; Vuolanto, Antti; Pesonen, Sari; Garofalo, Mariangela; Cerullo, Vincenzo; Jaderberg, Magnus
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice
2019 Garofalo, M; Villa, A; Rizzi, N; Kuryk, L; Rinner, B; Cerullo, V; Yliperttula, M; Mazzaferro, V; Ciana, P
Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice
2019 Leggiero, Eleonora; Labruna, Giuseppe; Iaffaldano, Laura; Lombardo, Barbara; Greco, Adelaide; Fiorenza, Dario; Gramanzini, Matteo; Montanaro, Donatella; Baldi, Alfonso; Cerullo, Vincenzo; Sacchetti, Lucia; Pastore, Lucio
Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor
2019 Fontana, F.; Fusciello, M.; Groeneveldt, C.; Capasso, C.; Chiaro, J.; Feola, S.; Liu, Z.; Makila, E. M.; Salonen, J. J.; Hirvonen, J. T.; Cerullo, V.; Santos, H. A.
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site
2019 Lopes, A.; Feola, S.; Ligot, S.; Fusciello, M.; Vandermeulen, G.; Preat, V.; Cerullo, V.
Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer Therapy
2019 Falanga, Andrea Patrizia; Cerullo, Vincenzo; Marzano, Maria; Feola, Sara; Oliviero, Giorgia; Piccialli, Gennaro; Borbone, Nicola
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy
2019 Ylosmaki, L.; Polini, B.; Carpi, S.; Martins, B.; Smertina, E.; Feola, S.; Fusciello, M.; Peltonen, K.; Nieri, P.; Ylosmaki, E.; Cerullo, V.
Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors
2018 Feola, S.; Capasso, C.; Fusciello, Celeste; Martins, B.; Tähtinen, S.; Medeot, M.; Carpi, S.; Frascaro, F.; Ylosmäki, E.; Peltonen, K.; Pastore, L.; Cerullo, V.
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses
2018 Ylösmäki, Erkko; Malorzo, Cristina; Capasso, Cristian; Honkasalo, Oona; Fusciello, Manlio; Martins, Beatriz; Ylösmäki, Leena; Louna, Antti; Feola, Sara; Paavilainen, Henrik; Peltonen, Karita; Hukkanen, Veijo; Viitala, Tapani; Cerullo, Vincenzo
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model
2018 Kuryk, Lukasz; Møller, Anne-Sophie W; Garofalo, Mariangela; Cerullo, Vincenzo; Pesonen, Sari; Alemany, Ramon; Jaderberg, Magnus
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma (vol 6, e1319028, 2017)
2017 Capasso, Cristian; Magarkar, Aniket; Cervera-Carrascon, Victor; Fusciello, Manlio; Feola, Sara; Mueller, Martin; Garofalo, Mariangela; Kuryk, Lukasz; Tahtinen, Siri; Pastore, Lucio; Bunker, Alex; Cerullo, Vincenzo
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma
2017 Capasso, Cristian; Magarkar, Aniket; Cervera carascon, Victor; Fusciello, Manlio; Feola, Sara; Muller, Martin; Garofalo, Mariangela; Kuryk, Lukasz; Tã¤htinen, Siri; Pastore, Lucio; Bunker, Alex; Cerullo, Vincenzo
Chronic activation of innate immunity correlates with poor prognosis in cancer patients treated with oncolytic adenovirus
2016 Taipale, Kristian; Liikanen, Ilkka; Juhila, Juuso; Turkki, Riku; Tähtinen, Siri; Kankainen, Matti; Vassilev, Lotta; Ristimäki, Ari; Koski, Anniina; Kanerva, Anna; Diaconu, Iulia; Cerullo, Vincenzo; Vähä-Koskela, Markus; Oksanen, Minna; Linder, Nina; Joensuu, Timo; Lundin, Johan; Hemminki, Akseli
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Design and application of oncolytic viruses for cancer immunotherapy | 1.1 Articolo in rivista | 2020 | Ylosmaki, E.; Cerullo, V. | |
| Exploiting preexisting immunity to enhance oncolytic cancer immunotherapy | 1.1 Articolo in rivista | 2020 | Tahtinen, S.; Feola, S.; Capasso, C.; Laustio, N.; Groeneveldt, C.; Ylosmaki, E. O.; Ylosmaki, L.; Martins, B.; Fusciello, M.; Medeot, M.; Tagliamonte, M.; Chiaro, J.; Hamdan, F.; Peltonen, K.; Ranki, T.; Buonaguro, L.; Cerullo, V. | |
| Application of array-comparative genomic hybridization analysis in immune-virotherapy approach | 1.1 Articolo in rivista | 2020 | Vitale, A.; Capasso, C.; Leggiero, E.; Garofalo, M.; Kuryk, L.; Hirvinen, M.; D'Alessio, F.; Perrotta, C.; Verdesca, F.; Ranieri, A.; Salvatore, F.; Pastore, L.; Buono, P.; Cerullo, V.; Lombardo, B. | |
| Uncovering the tumor antigen landscape: What to know about the discovery process | 1.1 Articolo in rivista | 2020 | Feola, S.; Chiaro, J.; Martins, B.; Cerullo, V. | |
| Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma | 1.1 Articolo in rivista | 2020 | Polini, B.; Carpi, S.; Doccini, S.; Citi, V.; Martelli, A.; Feola, S.; Santorelli, F. M.; Cerullo, V.; Romanini, A.; Nieri, P. | |
| Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction | 1.1 Articolo in rivista | 2020 | Torrieri, G.; Fontana, F.; Figueiredo, P.; Liu, Z.; Ferreira, M. P. A.; Talman, V.; Martins, J. P.; Fusciello, M.; Moslova, K.; Teesalu, T.; Cerullo, V.; Hirvonen, J.; Ruskoaho, H.; Balasubramanian, V.; Santos, H. A. | |
| Artificially cloaked viral nanovaccine for cancer immunotherapy | 1.1 Articolo in rivista | 2019 | Fusciello, M.; Fontana, F.; Tahtinen, S.; Capasso, C.; Feola, S.; Martins, B.; Chiaro, J.; Peltonen, K.; Ylosmaki, L.; Ylosmaki, E.; Hamdan, F.; Kari, O. K.; Ndika, J.; Alenius, H.; Urtti, A.; Hirvonen, J. T.; Santos, H. A.; Cerullo, V. | |
| Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks | 1.1 Articolo in rivista | 2019 | Kuryk, Lukasz; Møller, Anne-Sophie W; Vuolanto, Antti; Pesonen, Sari; Garofalo, Mariangela; Cerullo, Vincenzo; Jaderberg, Magnus | |
| Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice | 1.1 Articolo in rivista | 2019 | Garofalo, M; Villa, A; Rizzi, N; Kuryk, L; Rinner, B; Cerullo, V; Yliperttula, M; Mazzaferro, V; Ciana, P | |
| Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice | 1.1 Articolo in rivista | 2019 | Leggiero, Eleonora; Labruna, Giuseppe; Iaffaldano, Laura; Lombardo, Barbara; Greco, Adelaide; Fiorenza, Dario; Gramanzini, Matteo; Montanaro, Donatella; Baldi, Alfonso; Cerullo, Vincenzo; Sacchetti, Lucia; Pastore, Lucio | |
| Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor | 1.1 Articolo in rivista | 2019 | Fontana, F.; Fusciello, M.; Groeneveldt, C.; Capasso, C.; Chiaro, J.; Feola, S.; Liu, Z.; Makila, E. M.; Salonen, J. J.; Hirvonen, J. T.; Cerullo, V.; Santos, H. A. | |
| Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site | 1.1 Articolo in rivista | 2019 | Lopes, A.; Feola, S.; Ligot, S.; Fusciello, M.; Vandermeulen, G.; Preat, V.; Cerullo, V. | |
| Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer Therapy | 1.1 Articolo in rivista | 2019 | Falanga, Andrea Patrizia; Cerullo, Vincenzo; Marzano, Maria; Feola, Sara; Oliviero, Giorgia; Piccialli, Gennaro; Borbone, Nicola | |
| Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy | 1.1 Articolo in rivista | 2019 | Ylosmaki, L.; Polini, B.; Carpi, S.; Martins, B.; Smertina, E.; Feola, S.; Fusciello, M.; Peltonen, K.; Nieri, P.; Ylosmaki, E.; Cerullo, V. | |
| Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors | 1.1 Articolo in rivista | 2018 | Feola, S.; Capasso, C.; Fusciello, Celeste; Martins, B.; Tähtinen, S.; Medeot, M.; Carpi, S.; Frascaro, F.; Ylosmäki, E.; Peltonen, K.; Pastore, L.; Cerullo, V. | |
| Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses | 1.1 Articolo in rivista | 2018 | Ylösmäki, Erkko; Malorzo, Cristina; Capasso, Cristian; Honkasalo, Oona; Fusciello, Manlio; Martins, Beatriz; Ylösmäki, Leena; Louna, Antti; Feola, Sara; Paavilainen, Henrik; Peltonen, Karita; Hukkanen, Veijo; Viitala, Tapani; Cerullo, Vincenzo | |
| Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model | 1.1 Articolo in rivista | 2018 | Kuryk, Lukasz; Møller, Anne-Sophie W; Garofalo, Mariangela; Cerullo, Vincenzo; Pesonen, Sari; Alemany, Ramon; Jaderberg, Magnus | |
| A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma (vol 6, e1319028, 2017) | 1.1 Articolo in rivista | 2017 | Capasso, Cristian; Magarkar, Aniket; Cervera-Carrascon, Victor; Fusciello, Manlio; Feola, Sara; Mueller, Martin; Garofalo, Mariangela; Kuryk, Lukasz; Tahtinen, Siri; Pastore, Lucio; Bunker, Alex; Cerullo, Vincenzo | |
| A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma | 1.1 Articolo in rivista | 2017 | Capasso, Cristian; Magarkar, Aniket; Cervera carascon, Victor; Fusciello, Manlio; Feola, Sara; Muller, Martin; Garofalo, Mariangela; Kuryk, Lukasz; Tã¤htinen, Siri; Pastore, Lucio; Bunker, Alex; Cerullo, Vincenzo | |
| Chronic activation of innate immunity correlates with poor prognosis in cancer patients treated with oncolytic adenovirus | 1.1 Articolo in rivista | 2016 | Taipale, Kristian; Liikanen, Ilkka; Juhila, Juuso; Turkki, Riku; Tähtinen, Siri; Kankainen, Matti; Vassilev, Lotta; Ristimäki, Ari; Koski, Anniina; Kanerva, Anna; Diaconu, Iulia; Cerullo, Vincenzo; Vähä-Koskela, Markus; Oksanen, Minna; Linder, Nina; Joensuu, Timo; Lundin, Johan; Hemminki, Akseli |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile